NCT00456716View on ClinicalTrials.gov

Sorafenib in BAC or Never-Smokers With Lung Adenocarcinoma

PHASE2CompletedINTERVENTIONAL

Enrollment

5

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions

Lung Cancer

Interventions

DRUG

sorafenib

400mg po bid

Trial Locations (1)

98104

Swedish Cancer Institute, Seattle

Sponsors

Collaborators (2)

All Listed Sponsors

collaborator

Bayer

INDUSTRY

collaborator

Amgen

INDUSTRY

lead

Swedish Medical Center

OTHER